News

MNG Laboratories Now Accepting Reassessment of Sample Data

Evaluating your patient’s genetic data is critical to making important decisions and diagnosis. Changes to interpretations based on new findings and publications are an important part of characterizing and treating disorders of genetic origin and are critical to any laboratory relationship. We have reassessed samples run here at MNG on an ad-hoc basis and, as this service grows, we are pleased to provide a formal process to have your MNG data reassessed. MNG Laboratories understands the importance of reassessing data, especially as we continually update our processes, panels and test offerings based on the latest information and technology available. We also understand that, sometimes, a second opinion can help when you’d like your data, processed elsewhere, to be analyzed by the experts at MNG.

As of May 31, 2017, MNG Laboratories is proud to offer reassessment services of your genetic testing data! 

Our service offering covers the following data sets for reassessment:
  • Samples processed by MNG Laboratories:
    • MNG Exome™
    • MNG Panels
    • Variants
  • Samples processed outside of MNG Laboratories:
    • Exome
    • Variants
We utilize our proprietary bioinformatics pipeline, Genome MaNaGer™, and our Neurogenetic Answers™ reporting process to provide you with expert analysis and first-in-class reporting that provides actionable results you can count on.